|
Volumn 41, Issue 4, 2009, Pages 1347-1348
|
Combined Prophylaxis Decreases Incidence of CMV-Associated Pneumonia After Lung Transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
ANTIVIRUS AGENT;
CYTOMEGALOVIRUS ANTIBODY;
GANCICLOVIR;
UNCLASSIFIED DRUG;
VALGANCYCLOVIR;
VALGANCICLOVIR;
ARTICLE;
CLINICAL EVALUATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS INFECTION;
DISEASE ASSOCIATION;
DRUG EFFICACY;
FOLLOW UP;
GRAFT RECIPIENT;
HEALTH CENTER;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
LUNG TRANSPLANTATION;
MAJOR CLINICAL STUDY;
PNEUMONIA;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
TRANSBRONCHIAL BIOPSY;
TREATMENT OUTCOME;
ANALOGS AND DERIVATIVES;
CYTOMEGALOVIRUS INFECTIONS;
DRUG COMBINATION;
PNEUMONIA, VIRAL;
VIROLOGY;
ANTIVIRAL AGENTS;
CYTOMEGALOVIRUS INFECTIONS;
DRUG THERAPY, COMBINATION;
GANCICLOVIR;
HUMANS;
INCIDENCE;
LUNG TRANSPLANTATION;
PNEUMONIA, VIRAL;
|
EID: 65549161784
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2009.03.076 Document Type: Article |
Times cited : (14)
|
References (5)
|